TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Carmel Pharma AB
Closing information (x1000 EUR)
| Closing information | 2023/09 | 2022/09 | 2021/09 |
| Turnover |
6,228
|
6,236
|
5,535 |
| Financial expenses |
0
|
0
|
1 |
| Earnings before taxes |
7,182
|
6,240
|
5,706 |
| EBITDA |
6,098
|
6,132
|
5,400 |
| Total assets |
39,345
|
45,118
|
41,655 |
| Current assets |
157
|
1,428
|
2,158 |
| Current liabilities |
7,306
|
11,397
|
39 |
| Equity capital |
32,039
|
33,721
|
36,099 |
| - share capital |
771
|
812
|
869 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/09 | 2022/09 | 2021/09 |
| Solvency |
81.4%
|
74.7%
|
86.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
115.3%
|
100.1%
|
103.1% |
| Return on assets (ROA) |
18.3%
|
13.8%
|
13.7% |
| Current ratio |
2.1%
|
12.5%
|
5533.3% |
| Return on equity (ROE) |
22.4%
|
18.5%
|
15.8% |
| Change turnover |
304
|
1,064
|
-888 |
| Change turnover % |
5%
|
21%
|
-14% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/09 | 2022/09 | 2021/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.